Friday, September 9
Join us for the tenth anniversary of MedtechVision! Established in 2011, MedtechVision is an annual conference that brings together business leaders, inventors, investors, physicians and policymakers to discuss real-world solutions to the most challenging issues facing the Medtech industry today.
More than ever, complex, connected and convergent technologies are pushing medtech into new areas beyond the boundaries of the traditional realm of healthcare. Therapeutics as software, devices or digital platforms are extending the care continuum of non-invasive patient care. We are accessing healthcare where we work, sleep or eat e.g. getting a rapid diagnostic test in our car at a drive-through clinic, using an AI-supported wearable to monitor diabetes or remotely participating in the clinical trial of a new therapeutic.
Adoption of new healthcare technology has historically been a hurdle to scaling novel digital solutions. COVID went a long way in pulling the bandaid off technology acceptance and presented us with an opportunity for a reset, a re-examination of existing models and a continued embrace of unparalleled innovation: expanding the future of accessible patient care.
Join us as we discuss how to maintain this momentum and fully realize the promise of new medical technologies that are expanding our horizons.
Friday, September 9, 2022
7:30am – 6pm PDT
Stanford University Francis C. Arrillaga Alumni Center
326 Galvez St. Stanford, CA 94305
$100 for the virtual meeting
$1,250 for In-Person
REGISTER TO ATTEND IN PERSON
Register to attend Virtually
*This is a working agenda and subject to change.
Registration & Breakfast
Welcome from MedtechWomen & Stanford Biodesign
A word from our Founders
Patient Keynote – Melissa Muganzo Murphy
Melissa Muganzo Murphy is a multi – hypenate actor, humanitarian, activist, and community organizer. She serves as the CEO of Muganzo Entertainment and Executive Producer and Director of the 2022 feature length documentary “The Big Hysto: A Black Womb Revolution” – a visual call to action about medical racism and womb justice on behalf of all womb holders.
She is a proud graduate of UC Davis, recieivng her Bachelor’s degree in Community Regional Development in 2011, Sacramento State where she graduated with her master’s in Higher Education Leadership, and proud alum of Sacramento Entrepreneurship Academy where she earned her professional certificate in Global Entrepreneurship in 2018.
She is honored to be selected as MedtechVision 2022 patient keynote speaker and is proud to be a fibroid survivor and advocate. Follow her on Instagram at muganzoentertainment, Twitter @melissa_muganzo, LinkedIn @melissatlmuganzomurphy, or subscribe to her website www.muganzoentertainment.com.
Industry Landscape – Alira Health
Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. It works with healthcare and life sciences organizations looking for support across their entire solutions lifecycle, from development to medical care, through real-world evidence. As a sponsor of the MedtechWomen MedtechVision Conference,
Alira Health will be presenting a state of the Medtech Industry Report which will cover an overview of the innovation and advancement in the past decade for Medtech; a deep dive of the diagnostics market and its evolution, including commercial trends, key stakeholders and a future outlook. Additionally, the report will also explore the transformation in patient care that has been witnessed over the last ten years due to the advancement, integration and connectivity between Medtech, services, providers, payers. This report will serve as a snapshot of where the Medtech industry is and what can be expected in the future.
Diagnostic Renaissance: Ramping Up Rapid Testing and Remote Patient Monitoring
Lily Li, Principal, Northpond Ventures
Archana Dubey, Chief Clinical Officer, AliveCor Inc.
Susan Moon, Senior Vice President of the Customer & Digital Experience Team, Exact Sciences
Maital Rasmussen, Chief Commercial Officer, Octave Bioscience
Venture funding in global diagnostics startups increased >260% in 2021 vs. 2019 fueling a diagnostics renaissance (SV Bank Healthcare Report 2021). Point of care testing has been taken from the clinic and delivered directly to the patient’s door; digital technologies and wearables are enabling increased remote patient monitoring; and AI and machine learning are improving diagnostic solutions. These technologies can reduce resource pressures on hospitals and clinics as well as improve the speed and efficiency of the testing process and results. From COVID to cancer and from in-office to on-demand, this is a new industry and ours for the shaping.
Lunch & Networking
Ferolyn Powell Award
Remote Clinical Trials: Transitioning from the Traditional to the Modern
Megan Zweig, Chief Operating Officer, Rock Health
Jamie Wheeler, Senior Vice President, Global Clinical Affairs, Edwards Lifesciences
Kendal Whitlock, Head of Digital Optimization, RWE Clinical Trials, Walgreens Boots Alliance
Joyce Nortey, Sr. Director, Clinical Operations, Evidation Health
Remote clinical trials bypass the traditional limitations of site geography, improve participant diversity, and address the in-person staffing and data collection challenges that sharply limit the size of trials. They offer the rare value of reducing costs to sponsors while simultaneously improving the patient experience. The diagnostic renaissance and convergent technologies have continued to enable the expansion. However, regulatory guidance and industry standards are lagging. Clearing capturing the value of remote trials, while addressing their challenges will be key to moving remote trials from pandemic-era stop-gap to a new standard for medical device evaluation.
Executive Interview – Lisa Earnhardt, Abbott
Lisa Earnhardt, Executive Vice President, Medical Devices, Abbott
Kate Garrett, Managing Partner, Sonder Capital
The Promise of Convergent Technologies
Fiona Mack, Regional Head JLABS @ TMC, Johnson & Johnson
Natalia Birgisson, MD, Director of Strategy, Doximity
Kate Rosenbluth, PhD, Co-Founder & Chief Scientific Officer, Cala Health
Kavita Patel, MD, Venture Partner, New Enterprise Associates (NEA)
Kathleen Bauman, Vice President Product, Pear Therapeutics
The convergence of complex technology advancements in sensored wearables, miniaturization, telecommunications, software and new delivery models is creating a new horizon for disruptive, cost-efficient, healthcare solutions.
Paradigm shifts in medtech are transforming patient care from invasive to non-invasive, intervention to prevention, and hospitals to the home. We see technologies that can expand patient access via telehealth or wearables to more effectively manage chronic disease wherever the patient is located. Further, these novel convergent technologies are creating new definitions of therapeutics eg. bioelectronic medicine or digital platforms to better engage, educate and treat patients.
Chief Clinical Officer
Regional Head JLABS @ TMC
Johnson & Johnson
Senior Vice President, Global Clinical Affairs
Sr. Director, Clinical Operations
Founder & Chief Science Officer
Vice President, Product
New Enterprise Associates (NEA)
Head of Digital Optimization, RWE Clinical Trials
Walgreens Boots Alliance
North Pond Ventures
Executive Vice President, Medical Devices
Chief Commercial Officer
Chief Operating Officer
Director of Strategy
Sr. Vice President, Customer & Digital Experience
Moderators will be added as bios become available.
Then become a sponsor for one of our future events. See our Sponsorship page for more information.
Become a Sponsor